{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:12:21Z","timestamp":1774674741010,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.carrev.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T07:32:06Z","timestamp":1392449526000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: Results from the ISAR-DESIRE 2 trial"],"prefix":"10.1016","volume":"15","author":[{"given":"Sebastian","family":"Kufner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"de Waha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Ludwig","family":"Laugwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2014.02.001_bb0005","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0735-1097(98)00467-7","article-title":"Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement","volume":"32","author":"Elezi","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0010","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.amjcard.2010.01.007","article-title":"Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark","volume":"105","author":"Jensen","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0965-206X(04)44002-9","article-title":"A clinical study and the national service framework for diabetes","volume":"14","author":"Barry","year":"2004","journal-title":"J Tissue Viability"},{"key":"10.1016\/j.carrev.2014.02.001_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4244\/EIJV9I1A10","article-title":"Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting","volume":"9","author":"Iqbal","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2014.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.02.001_bb0030","first-page":"944","article-title":"Is there a preferable DES in diabetic patients? A critical appraisal of the evidence","volume":"72","author":"Byrne","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.02.001_bb0035","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.jacc.2010.10.006","article-title":"Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)","volume":"56","author":"Kereiakes","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0040","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","article-title":"Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus","volume":"124","author":"Stone","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.02.001_bb0045","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4244\/EIJV9I7A132","article-title":"Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials","volume":"9","author":"Byrne","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2014.02.001_bb0050","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study","volume":"55","author":"Mehilli","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0055","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1161\/01.CIR.100.18.1872","article-title":"Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome","volume":"100","author":"Mehran","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.02.001_bb0060","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.02.001_bb0065","first-page":"494","article-title":"Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients","volume":"77","author":"Birkmeier","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.02.001_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2011.05.086","article-title":"An updated meta-analysis of randomized controlled trials of everolimus- versus paclitaxel-eluting stents","volume":"151","author":"Takagi","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0075","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"Schomig","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0080","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.jacc.2008.03.028","article-title":"Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis","volume":"51","author":"Mahmud","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2009.08.652","article-title":"Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus","volume":"105","author":"Zhang","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0090","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ahj.2011.07.003","article-title":"A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease","volume":"162","author":"Kufner","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2014.02.001_bb0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0735-1097(98)00286-1","article-title":"The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation","volume":"32","author":"Abizaid","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0100","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/01.ATV.0000223866.42883.3b","article-title":"Comparative effects of paclitaxel and rapamycin on smooth muscle migration and survival: role of AKT-dependent signaling","volume":"26","author":"Patterson","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4244\/EIJV9I7A132","article-title":"Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; evidence in support of drug resistance: insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials","volume":"9","author":"Byrne","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2014.02.001_bb0110","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ahj.2006.12.009","article-title":"Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent","volume":"153","author":"Cosgrave","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2014.02.001_bb0115","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcin.2012.03.017","article-title":"Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent])","volume":"5","author":"Alfonso","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.02.001_bb0120","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa044372","article-title":"Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients","volume":"353","author":"Dibra","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.02.001_bb0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1540-8183.2008.00353.x","article-title":"Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients","volume":"21","author":"Kim","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacc.2008.04.056","article-title":"A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus","volume":"52","author":"Lee","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjcard.2008.09.084","article-title":"Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial","volume":"103","author":"Maeng","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2337\/dc07-1377","article-title":"Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study","volume":"31","author":"Tomai","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.carrev.2014.02.001_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCINTERVENTIONS.110.957175","article-title":"Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberte stents in de novo native coronary artery lesions","volume":"4","author":"Otake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.02.001_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2009.08.652","article-title":"Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus","volume":"105","author":"Zhang","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/heartjnl-2012-302945","article-title":"Drug-eluting balloon angioplasty for in-stent restenosis: a systematic review and meta-analysis of randomised controlled trials","volume":"99","author":"Indermuehle","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2014.02.001_bb0160","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.110.015453","article-title":"Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.02.001_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/028418518802900308","article-title":"Increased arterial wall stiffness and thickness in medium-sized arteries in patients with insulin-dependent diabetes mellitus","volume":"29","author":"Christensen","year":"1988","journal-title":"Acta Radiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0170","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.amjcard.2007.04.036","article-title":"Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents","volume":"100","author":"Roy","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2014.02.001_bb0175","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2007.06.005","article-title":"Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era","volume":"154","author":"Iijima","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2014.02.001_bb0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography","volume":"100","author":"Cassese","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2014.02.001_bb0185","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.105.601823","article-title":"Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents","volume":"113","author":"Kastrati","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.02.001_bb0190","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.02.001_bb0195","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2014.02.001_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jacc.2006.02.060","article-title":"Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial","volume":"48","author":"Pinto","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914000475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914000475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:10:12Z","timestamp":1761559812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838914000475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1553838914000475"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2014.02.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: Results from the ISAR-DESIRE 2 trial","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}